DNB Fund - Biotechnology C1 CHF (Acc) Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 134920647 |
| ISIN | LU2814038696 |
| Name | DNB Fund - Biotechnology C1 CHF (Acc) Fonds |
| Fondsgesellschaft | DNB Asset Management |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 06.06.2024 |
| Kategorie | Branchen: Biotechnologie |
| Währung | CHF |
| Volumen | 5’635’757.58 |
| Depotbank | Bank Pictet & Cie (Europe) AG succursale Luxembourg |
| Zahlstelle | |
| Fondsmanager | Rune Sand |
| Geschäftsjahresende | 31.12. |
| Berichtsstand | 01.07.2026 |
Anlagepolitik
So investiert der DNB Fund - Biotechnology C1 CHF (Acc) Fonds: The Sub-Fund seeks to invest mainly in equities of companies operating in or associated with the biotechnology, diagnostics, pharmaceuticals, biomedicine, gene therapy and other health care related industries, with the aim to achieve a positive relative return over the long- term. Geographically the Sub-Fund has full flexibility.